A novel mitochondrial m.14430A>G (MT-ND6, p.W82R) variant causes complex I deficiency and mitochondrial Leigh syndrome
-
Miaomiao Du
, Jianxin Lyu
and Hezhi Fang
Abstract
Objectives
Leigh syndrome (LS) is one of the most common mitochondrial diseases and has variable clinical symptoms. However, the genetic variant spectrum of this disease is incomplete.
Methods
Next-generation sequencing (NGS) was used to identify the m.14430A > G (p.W82R) variant in a patient with LS. The pathogenesis of this novel complex I (CI) variant was verified by determining the mitochondrial respiration, assembly of CI, ATP, MMP and lactate production, and cell growth rate in cybrids with and without this variant.
Results
A novel m.14430A > G (p.W82R) variant in the NADH dehydrogenase 6 (ND6) gene was identified in the patient; the mutant loads of m.14430A > G (p.W82R) in the patient were much higher than those in his mother. Although the transmitochondrial cybrid-based study showed that mitochondrial CI assembly remains unaffected in cells with the m.14430G variant, control cells had significantly higher endogenous and CI-dependent mitochondrial respiration than mutant cells. Accordingly, mutant cells had a lower ATP, MMP and higher extracellular lactate production than control cells. Notably, mutant cells had impaired growth in a galactose-containing medium when compared to wild-type cells.
Conclusions
A novel m.14430A > G (p.W82R) variant in the ND6 gene was identified from a patient suspected to have LS, and this variant impaired mitochondrial respiration by decreasing the activity of mitochondrial CI.
Acknowledgments
We thank the National Natural Science Foundation of China (key program, 81830071, Funder Id: http://dx.doi.org/10.13039/501100001809) and Zhejiang Provincial Natural Science Foundation of China (LR20H200001) for supporting this work.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Research funding: This work was supported by the National Natural Science Foundation of China (key program, 81830071) and Zhejiang Provincial Natural Science Foundation of China (LR20H200001).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: Authors state no conflict of interest.
Informed consent: Informed consent was obtained from all individuals included in this study.
Ethical approval: This study was approved by the Ethics Committee of Peking University First Hospital (No. 2017-217).
References
1. Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S. Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol 2017;13:92–104.10.1038/nrendo.2016.151Search in Google Scholar PubMed
2. Frazier AE, Thorburn DR, Compton AG. Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology. J Biol Chem 2019;294:5386–95.10.1074/jbc.R117.809194Search in Google Scholar PubMed PubMed Central
3. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr Neurol 2008;39:223–35.10.1016/j.pediatrneurol.2008.07.013Search in Google Scholar PubMed
4. Xu B, Li X, Du M, Zhou C, Fang H, Lyu J, et al. Novel mutation of ND4 gene identified by targeted next-generation sequencing in patient with Leigh syndrome. J Hum Genet 2017;62:291–7.10.1038/jhg.2016.127Search in Google Scholar PubMed
5. Rahman S, Blok RB, Dahl HH, Danks DM, Kirby DM, Chow CW, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996;39:343–51.10.1002/ana.410390311Search in Google Scholar PubMed
6. Jain IH, Zazzeron L, Goldberger O, Marutani E, Wojtkiewicz GR, Ast T, et al. Leigh Syndrome mouse model can be rescued by interventions that normalize brain hyperoxia, but not HIF activation. Cell Metab 2019;30:824–32.e3.10.1016/j.cmet.2019.07.006Search in Google Scholar PubMed PubMed Central
7. Lake NJ, Compton AG, Rahman S, Thorburn DR. Leigh syndrome: one disorder, more than 75 monogenic causes. Ann Neurol 2016;79:190–203.10.1002/ana.24551Search in Google Scholar PubMed
8. Mani S, Rao SN, Kranthi Kumar MV. Genetic heterogeneity of mitochondrial genome in thiamine deficient Leigh syndrome patients. J Neurol Sci 2019;404:91–100.10.1016/j.jns.2019.07.007Search in Google Scholar PubMed
9. Ichikawa K, Tsuyusaki Y, Shimbo H, Goto T. Late-onset Leigh syndrome with m.9176T>C mutation in the mitochondrial ATPase 6 gene. Pediatr Int 2019;61:1055–6.10.1111/ped.13991Search in Google Scholar PubMed
10. Takada R, Tozawa T, Kondo H, Kizaki Z, Kishita Y, Okazaki Y, et al. Early infantile-onset Leigh syndrome complicated with infantile spasms associated with the m.9185T>C variant in the MT-ATP6 gene: expanding the clinical spectrum. Brain Dev 2020;42: 69–72.10.1016/j.braindev.2019.08.006Search in Google Scholar PubMed
11. Ro S, Ma HY, Park C, Ortogero N, Song R, Hennig GW, et al. The mitochondrial genome encodes abundant small noncoding RNAs. Cell Res 2013;23:759–74.10.1038/cr.2013.37Search in Google Scholar
12. Baracca A, Solaini G, Sgarbi G, Lenaz G, Baruzzi A, Schapira AH, et al. Severe impairment of complex I-driven adenosine triphosphate synthesis in leber hereditary optic neuropathy cybrids. Arch Neurol 2005;62:730–6.10.1001/archneur.62.5.730Search in Google Scholar
13. Ferreira M, Torraco A, Rizza T, Fattori F, Meschini MC, Castana C, et al. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics 2011;12:9–17.10.1007/s10048-010-0265-2Search in Google Scholar
14. Chomyn A, Lai ST, Shakeley R, Bresolin N, Scarlato G, Attardi G. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals – and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am J Hum Genet 1994;54:966–74.Search in Google Scholar
15. Calvo SE, Compton AG, Hershman SG, Lim SC, Lieber DS, Tucker EJ, et al. Molecular diagnosis of infantile mitochondrial disease with targeted next-generation sequencing. Sci Transl Med 2012;4:118ra10.10.1126/scitranslmed.3003310Search in Google Scholar
16. Qamar W, Khan MR, Arafah A. Optimization of conditions to extract high quality DNA for PCR analysis from whole blood using SDS-proteinase K method. Saudi J Biol Sci 2017;24: 1465–9.10.1016/j.sjbs.2016.09.016Search in Google Scholar
17. Wittig I, Braun HP, Schagger H. Blue native PAGE. Nat Protoc 2006;1:418–28.10.1038/nprot.2006.62Search in Google Scholar
18. Bai Y, Attardi G. The mtDNA-encoded ND6 subunit of mitochondrial NADH dehydrogenase is essential for the assembly of the membrane arm and the respiratory function of the enzyme. Embo J 1998;17:4848–58.10.1093/emboj/17.16.4848Search in Google Scholar
19. Kirby DM, Kahler SG, Freckmann ML, Reddihough D, Thorburn DR. Leigh disease caused by the mitochondrial DNA G14459A mutation in unrelated families. Ann Neurol 2000;48:102–4.10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.0.CO;2-MSearch in Google Scholar
20. Ravn K, Wibrand F, Hansen FJ, Horn N, Rosenberg T, Schwartz M. An mtDNA mutation, 14453G–>A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome. Eur J Hum Genet 2001;9:805–9.10.1038/sj.ejhg.5200712Search in Google Scholar
21. Chinnery PF, Brown DT, Andrews RM, Singh-Kler R, Riordan-Eva P, Lindley J, et al. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber’s hereditary optic neuropathy. Brain 2001;124:209–18.10.1093/brain/124.1.209Search in Google Scholar
22. Ugalde C, Triepels RH, Coenen MJ, van den Heuvel LP, Smeets R, Uusimaa J, et al. Impaired complex I assembly in a Leigh syndrome patient with a novel missense mutation in the ND6 gene. Ann Neurol 2003;54:665–9.10.1002/ana.10734Search in Google Scholar
23. Uehara N, Mori M, Tokuzawa Y, Mizuno Y, Tamaru S, Kohda M, et al. New MT-ND6 and NDUFA1 mutations in mitochondrial respiratory chain disorders. Ann Clin Transl Neurol 2014;1:361–9.10.1002/acn3.59Search in Google Scholar
24. Malfatti E, Bugiani M, Invernizzi F, de Souza CF, Farina L, Carrara F, et al. Novel mutations of ND genes in complex I deficiency associated with mitochondrial encephalopathy. Brain 2007;130:1894–904.10.1093/brain/awm114Search in Google Scholar
25. Lee S, Na JH, Lee YM. Epilepsy in leigh syndrome with mitochondrial DNA mutations. Front Neurol 2019;10:496.10.3389/fneur.2019.00496Search in Google Scholar
26. Bandelt HJ, Salas A, Bravi CM. What is a ‘novel’ mtDNA mutation – and does ‘novelty’ really matter? J Hum Genet 2006;51:1073–82.10.1007/s10038-006-0066-5Search in Google Scholar
27. Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 2005;24:1455–60.10.1038/sj.onc.1208292Search in Google Scholar
28. Fang H, Shi H, Li X, Sun D, Li F, Li B, et al. Exercise intolerance and developmental delay associated with a novel mitochondrial ND5 mutation. Sci Rep 2015;5:10480.10.1038/srep10480Search in Google Scholar
29. Yao YG, Kong QP, Salas A, Bandelt HJ. Pseudomitochondrial genome haunts disease studies. J Med Genet 2008;45:769–72.10.1136/jmg.2008.059782Search in Google Scholar
30. Cardol P, Matagne RF, Remacle C. Impact of mutations affecting ND mitochondria-encoded subunits on the activity and assembly of complex I in Chlamydomonas. Implication for the structural organization of the enzyme. J Mol Biol 2002;319:1211–21.10.1016/S0022-2836(02)00407-2Search in Google Scholar
31. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci U S A 1994;91:6206–10.10.1073/pnas.91.13.6206Search in Google Scholar PubMed PubMed Central
©2020 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- Biotin interference in cardiac troponin immunoassay – where the wild things are?
- Review
- Laboratory-related issues in the measurement of cardiac troponins with highly sensitive assays
- Mini Review
- Chromatographic methods development for clinical practice: requirements and limitations
- Opinion Paper
- Harmonising EQA schemes the next frontier: challenging the status quo
- Genetics and Molecular Diagnostics
- Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients
- A novel mitochondrial m.14430A>G (MT-ND6, p.W82R) variant causes complex I deficiency and mitochondrial Leigh syndrome
- Obesity status modifies the association between rs7556897T>C in the intergenic region SLC19A3-CCL20 and blood pressure in French children
- General Clinical Chemistry and Laboratory Medicine
- Influence of reagent lots and multiple measuring systems on estimating the coefficient of variation from quality control data; implications for uncertainty estimation and interpretation of QC results
- Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants
- A continued method performance monitoring approach for the determination of pediatric renin samples – application within a European clinical trial
- Pilot study for cystic fibrosis neonatal screening: the Cuban experience
- Validation of the analytical performance of the NOVEOS™ System, a system which improves upon the third-generation in vitro allergy testing technology
- IgE cross-reactivity measurement of cashew nut, hazelnut and peanut using a novel IMMULITE inhibition method
- Sexual dimorphism in the cerebrospinal fluid total protein content
- Current state of the morphological assessment of urinary erythrocytes in The Netherlands: a nation-wide questionnaire
- Reference Values and Biological Variations
- Within-subject and between-subject biological variation of first morning void urine amino acids in 12 healthy subjects
- Proenkephalin as a new biomarker for pediatric acute kidney injury – reference values and performance in children under one year of age
- Hematology and Coagulation
- Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data
- Cardiovascular Diseases
- Clinical risk assessment of biotin interference with a high-sensitivity cardiac troponin T assay
- Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy
- Infectious Diseases
- Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department
- Performance of a Toxo IgM prototype assay for the diagnosis of maternal and congenital Toxoplasma infections
- Letters to the Editors
- Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer
- Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay
- Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization
- Total pathway to method validation
- Derivation of performance specifications for uncertainty of serum C-reactive protein measurement according to the Milan model 3 (state of the art)
- FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference
- Use of a modified IDS-ISYS intact PTH assay for intraoperative PTH measurements
- Agreement of dried blood spot lyso-Gb3 concentrations obtained from different laboratories in patients with Fabry disease
- Influence of delayed separation of plasma from whole blood and centrifugation protocol on Zn plasma concentration
- A survey of order of draw on inpatient wards and adherence to EFLM-COLABIOCLI recommendations
- Successful implementations of automated minimum re-test intervals to overcome ferritin over-requesting in a Spanish hospital laboratory
- Remarkable pseudoleucocytosis induced by mild cryoglobulinemia
- Massive hemolysis due to Clostridium perfringens: a laboratory’s perspective
Articles in the same Issue
- Frontmatter
- Editorial
- Biotin interference in cardiac troponin immunoassay – where the wild things are?
- Review
- Laboratory-related issues in the measurement of cardiac troponins with highly sensitive assays
- Mini Review
- Chromatographic methods development for clinical practice: requirements and limitations
- Opinion Paper
- Harmonising EQA schemes the next frontier: challenging the status quo
- Genetics and Molecular Diagnostics
- Direct comparison study between droplet digital PCR and a combination of allele-specific PCR, asymmetric rapid PCR and melting curve analysis for the detection of BRAF V600E mutation in plasma from melanoma patients
- A novel mitochondrial m.14430A>G (MT-ND6, p.W82R) variant causes complex I deficiency and mitochondrial Leigh syndrome
- Obesity status modifies the association between rs7556897T>C in the intergenic region SLC19A3-CCL20 and blood pressure in French children
- General Clinical Chemistry and Laboratory Medicine
- Influence of reagent lots and multiple measuring systems on estimating the coefficient of variation from quality control data; implications for uncertainty estimation and interpretation of QC results
- Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants
- A continued method performance monitoring approach for the determination of pediatric renin samples – application within a European clinical trial
- Pilot study for cystic fibrosis neonatal screening: the Cuban experience
- Validation of the analytical performance of the NOVEOS™ System, a system which improves upon the third-generation in vitro allergy testing technology
- IgE cross-reactivity measurement of cashew nut, hazelnut and peanut using a novel IMMULITE inhibition method
- Sexual dimorphism in the cerebrospinal fluid total protein content
- Current state of the morphological assessment of urinary erythrocytes in The Netherlands: a nation-wide questionnaire
- Reference Values and Biological Variations
- Within-subject and between-subject biological variation of first morning void urine amino acids in 12 healthy subjects
- Proenkephalin as a new biomarker for pediatric acute kidney injury – reference values and performance in children under one year of age
- Hematology and Coagulation
- Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data
- Cardiovascular Diseases
- Clinical risk assessment of biotin interference with a high-sensitivity cardiac troponin T assay
- Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy
- Infectious Diseases
- Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department
- Performance of a Toxo IgM prototype assay for the diagnosis of maternal and congenital Toxoplasma infections
- Letters to the Editors
- Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer
- Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay
- Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization
- Total pathway to method validation
- Derivation of performance specifications for uncertainty of serum C-reactive protein measurement according to the Milan model 3 (state of the art)
- FGF23 measurement in burosumab-treated patients: an emerging treatment may induce a new analytical interference
- Use of a modified IDS-ISYS intact PTH assay for intraoperative PTH measurements
- Agreement of dried blood spot lyso-Gb3 concentrations obtained from different laboratories in patients with Fabry disease
- Influence of delayed separation of plasma from whole blood and centrifugation protocol on Zn plasma concentration
- A survey of order of draw on inpatient wards and adherence to EFLM-COLABIOCLI recommendations
- Successful implementations of automated minimum re-test intervals to overcome ferritin over-requesting in a Spanish hospital laboratory
- Remarkable pseudoleucocytosis induced by mild cryoglobulinemia
- Massive hemolysis due to Clostridium perfringens: a laboratory’s perspective